CoChat

A Pilot Study Demonstrating Clinical Benefit From Intralesional Interferon Alpha 2B in the Treatment of Peyronie's Disease

Open access
AHUJA, SUNIL, BIVALACQUA, TRINITY J., CASE, JOHN, VINCENT, MARK, SJXKA, SURESH C., HELLSTROM, WAYNE J. G. · 1999 · Journal of Andrology
Cited by 60

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Intralesional therapy is a less invasive method for the treatment of Peyronie's disease. The objective of this study was to evaluate intralesional injections of interferon alpha 2B (IFN‐α‐2B) as an effective alternative to the surgical treatment of Peyronie's disease. Twenty‐one patients with Peyronie's disease were evaluated by use of penile duplex Doppler ultrasonography for cavernosal blood flows, degree of penile curvature, and plaque size. A questionnaire was given to all patients to assess sexual function. Each patient then received biweekly intralesional injections of 1 × 10 6 units of IFN‐α‐2B in 10 ml of normal saline over a period of 6 months. There was no placebo control group in this study. At the conclusion of the study, penile duplex Doppler imaging was repeated. A questionnaire was completed by all patients to assess changes in sexufunction after treatment. Twenty patients completed the study, with all men reporting subjective softening of their plaques. Nine of 10 patients initially reporting penile pain with erection (90%) had resolution of their phallalgia while on study protocol. Thirteen patients (65%) had significant improvement in curvature, ranging from 20 to 90%. Seventeen patients (85%) demonstrated an objective 10 to 80% decrease in plaque size. Biweekly intralesional injections of Peyronie's plaques with IFN‐α‐2B resulted in a significant improvement in penile curvature, diminished pain, and reduced plaque size, and resulted in a subjective improvement in sexual function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/j.1939-4640.1999.tb02539.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 60

Metadata

Authors
AHUJA, S., BIVALACQUA, T. J., CASE, J., VINCENT, M., SJXKA, S. C., & HELLSTROM, W. J. G.
Venue
Journal of Andrology
Publisher
Wiley
Published
1999-07-08
Volume
20
Issue
4
Pages
444-448
ISSN
  • 0196-3635 (ISSN-L)
  • 1939-4640
OpenAlex
W1570494766
Cited by
60
References
4
FWCI
2.19
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Pilot Study Demonstrating Clinical Benefit From Intralesional Interferon Alpha 2B in the Treatment of Peyronie's Disease. https://app.cochat.ai/papers/10.1002/j.1939-4640.1999.tb02539.x
The paper
AHUJA, S., BIVALACQUA, T. J., CASE, J., VINCENT, M., SJXKA, S. C., & HELLSTROM, W. J. G. (1999). A Pilot Study Demonstrating Clinical Benefit From Intralesional Interferon Alpha 2B in the Treatment of Peyronie's Disease. Journal of Andrology. https://doi.org/10.1002/j.1939-4640.1999.tb02539.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.